LMG Life Sciences named John Desmarais, partner at Desmarais LLP, as its General Patent Litigator of the Year (New York) in the 2025 Americas Awards.
During the past year, Desmarais helped oversee three successive victories before the Federal Circuit that upheld patents that formed the basis of $429.5 million in damages secured in the district courts for Ravgen’s non-invasive prenatal genetic testing technology. Those damages include a $272.5 million jury verdict – later enhanced to $372.5 million – that Desmarais won for Ravgen against Labcorp.
The annual LMG Life Sciences Americas Awards highlight the industry’s leading firms and practitioners handling life sciences matters. LMG selects the winners based on feedback from industry peers and clients and successes achieved during the prior 12 months across the regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement industry sectors.
See the LMG Life Sciences Americas Awards winners
Desmarais LLP Shortlisted for American Lawyer’s Specialty Litigation Dept. of the Year Award
Accolades
The American Lawyer selected Desmarais LLP as a finalist in the “National Boutique/Specialty Litigation Department of the Year” category for its 2025 Industry Awards. The recognition highlights Desmarais LLP’s major litigation successes...
MORE